BIOCEPT INC·4

Mar 22, 4:16 PM ET

BIOCEPT INC 4

4 · BIOCEPT INC · Filed Mar 22, 2017

Insider Transaction Report

Form 4
Period: 2017-03-21
Nall Michael W.
DirectorCEO AND PRESIDENT
Transactions
  • Award

    Employee stock option (right to buy)

    2017-03-21+6,3336,333 total
    Exercise: $6.03From: 2017-03-21Exp: 2025-08-30Common Stock (6,333 underlying)
  • Award

    Employee stock option (right to buy)

    2017-03-21+10,00010,000 total
    Exercise: $4.02From: 2017-03-21Exp: 2026-02-28Common Stock (10,000 underlying)
Footnotes (2)
  • [F1]On August 31, 2015, the reporting person was granted an option to purchase shares of the Issuer's common stock that was to vest upon the achievement of corporate goals. On March 21, 2017, the Issuer's Board of Directors confirmed the achievement of such goals.
  • [F2]On February 29, 2016, the reporting person was granted an option to purchase shares of the Issuer's common stock that was to vest upon the achievement of corporate goals. On March 21, 2017, the Issuer's Board of Directors confirmed the achievement of such goals.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION